Comparison of coronary plaque, coronary artery calcification and major adverse cardiac events in Chinese outpatients with and without type 2 diabetes

SpringerPlus

Table 1 Clinical characteristics in diabetes and non-diabetes groups

Variables	Total (N = 588)	Diabetes (N = 208)	Non-diabetes (N = 380)	p
Age (years)	61.06 ± 11.89	61.91 ± 10.57	60.60 ± 12.55	0.179
Sex, male (%)	372 (63.3)	118 (56.7)	254 (66.8)	0.016
Hypertension [n (%)]	380 (64.6)	141 (67.8)	239 (62.9)	0.242
Smoking [n (%)]	264 (44.9)	86 (41.3)	178 (46.8)	0.225
BMI (Kg/m²)	25.54 ± 3.480	26.11 ± 2.668	25.23 ± 3.821	0.001
CHOL (mmol/l)	4.70 ± 0.934	4.78 ± 0.967	4.66 ± 0.915	0.170
TG (mmol/l)	1.70 ± 1.309	1.79 ± 1.168	1.65 ± 1.379	0.232
HDL-C (mmol/l)	1.19 ± 0.320	1.12 ± 0.304	1.22 ± 0.323	<0.001
LDL-C (mmol/l)	2.67 ± 0.691	2.74 ± 0.737	2.63 ± 0.663	0.078
APOA1 (g/l)	1.15 ± 0.229	1.14 ± 0.224	1.16 ± 0.232	0.458
APOA100 (g/l)	0.95 ± 0.261	0.96 ± 0.227	0.95 ± 0.277	0.463
LPa (mg/dl)	21.97 ± 17.800	23.97 ± 17.910	20.88 ± 17.668	0.044
HCY (µmol/l)	17.89 ± 8.533	17.12 ± 6.577	18.31 ± 9.416	0.074
CYSC (mg/l)	0.97 ± 0.282	1.02 ± 0.340	0.94 ± 0.240	0.002

Data are expressed as the mean ± SD and number (percentage)
BMI body mass index, CHOL cholesterol, TG triglycerides, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, APO apolipoprotein, LPa lipoprotein a, HCY homocysteine, T score total coronary artery calcification scores, MI myocardial infarction